Rhythm Pharmaceuticals annual gross profit
2021
2022
2023
2024
2025
Rhythm Pharmaceuticals Gross Profit Growth & History (RYTM)
Rhythm Pharmaceuticals's gross profit was $170.3M for fiscal 2025.
View full Rhythm Pharmaceuticals company overviewRhythm Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $170.3M | $53.5M | +45.83% |
| 2024 | 2024-12-31 | $116.8M | $48.6M | +71.39% |
| 2023 | 2023-12-31 | $68.1M | $46.6M | +216.79% |
| 2022 | 2022-12-31 | $21.5M | $18.9M | +741.68% |
| 2021 | 2021-12-31 | $2.6M | — | — |
Rhythm Pharmaceuticals quarterly gross profit
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $62.3M | $19.4M | +45.08% |
| Q1 2026 | 2026-03-31 | $53.0M | $23.9M | +82.25% |
| Q4 2025 | 2025-12-31 | $52.5M | $14.4M | +37.87% |
| Q3 2025 | 2025-09-30 | $45.8M | $16.4M | +55.66% |
| Q2 2025 | 2025-06-30 | $43.0M | $16.8M | +64.40% |
| Q1 2025 | 2025-03-31 | $29.1M | $5.9M | +25.46% |
| Q4 2024 | 2024-12-31 | $38.0M | $17.0M | +81.15% |
| Q3 2024 | 2024-09-30 | $29.4M | $9.3M | +46.44% |
| Q2 2024 | 2024-06-30 | $26.1M | $9.1M | +53.85% |
| Q1 2024 | 2024-03-31 | $23.2M | $13.1M | +130.49% |
| Q4 2023 | 2023-12-31 | $21.0M | $13.2M | +170.56% |
| Q3 2023 | 2023-09-30 | $20.1M | $16.3M | +430.55% |
| Q2 2023 | 2023-06-30 | $17.0M | $8.3M | +95.50% |
| Q1 2023 | 2023-03-31 | $10.0M | $8.8M | +692.43% |
| Q4 2022 | 2022-12-31 | $7.8M | $6.2M | +390.96% |
| Q3 2022 | 2022-09-30 | $3.8M | $3.0M | +369.85% |
| Q2 2022 | 2022-06-30 | $8.7M | $8.6M | +6241.61% |
| Q1 2022 | 2022-03-31 | $1.3M | $1.2M | +3990.32% |
| Q4 2021 | 2021-12-31 | $1.6M | — | — |
| Q3 2021 | 2021-09-30 | $806,000 | — | — |
| Q2 2021 | 2021-06-30 | $137,000 | — | — |
| Q1 2021 | 2021-03-31 | $31,000 | — | — |
Rhythm Pharmaceuticals gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Rhythm Pharmaceuticals's gross profit increased from $2.6M to $170.3M, a change of $167.7M. The latest reported quarter, Q2 2026, shows $62.3M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rhythm Pharmaceuticals source filings ↗